전체 프로그램

ADCBiologicstaleIksuda Therapeutics Ltd.Phase 1

IKS014 (IKS014)

Breast Cancer; Gastric Cancer · Breast Cancer

#BreastCancer#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2

CGTBiologicstaleThe Methodist Hospital Research…Phase 2

IL-12 gene therapy (IL-12 gene therapy)

Triple Negative Breast Cancer; Anthracycline-refractory TNBC · FRα

#FR#CGT#Phase2#세포유전치료#CAR-T+4

효능 ORR 90%임상시험 1상태 DISCONTINUED

CGTBiologicstaleGenovn Therapeutics (Suzhou) Co…Phase 1

IL-15 enhanced engineered NK cells (IL-15 enhanced engineered NK cells)

Solid Tumors; Metastatic Cancer · Solid Tumors

#SolidTumors#CGT#Phase1#세포유전치료#CAR-T+3

CGTBiologicstaleThe First Hospital of Jilin Uni…Phase 2

IL-15-armored CAR-T cells (IL-15-armored CAR-T cells)

Relapsed/Refractory Multiple Myeloma; Plasma Cell Leukemia (PCL) · FRα

#FR#CGT#Phase2#세포유전치료#CAR-T+5

효능 ORR 50%임상시험 1상태 RECRUITING

AntibodyBiologicstaleSecond Affiliated Hospital, Sch…Approved

IL-17A/F mAb + NAFL (IL-17A/F mAb + NAFL)

Hidradenitis Suppurativa (HS) · Hidradenitis Suppurativa (HS)

#HidradenitisSuppurativaHS#Antibody#Approved#항체#면역항체+2

AntibodystaleGregory DanielsPhase 2

nivolumab (Opdivo, IL-2 and Nivolumab)

Melanoma Stage Iv; Renal Cell Carcinoma, Metastatic · Melanoma Stage Iv

#MelanomaStageIv#Antibody#Phase2#항체#면역항체+4

CGTBiologicstaleZhejiang UniversityPhase 1

IL-5 CAR-T cells (IL-5 CAR-T cells)

Hematologic Diseases; Neoplasms · Hematologic Diseases

#HematologicDiseases#CGT#Phase1#세포유전치료#CAR-T+3

CGTBiologicstaleBristol-Myers SquibbPhase 1

IL13Ralpha2-specific Hinge-optimized 4-1BB-co-stimulatory CAR/Truncated CD19-expressing Autologous TN/MEM Cells (IL13Ralpha2-specific Hinge-optimized 4-1BB-co-stimulatory CAR/Truncated CD19-expressing Autologous TN/MEM Cells)

Recurrent Glioblastoma; Refractory Glioblastoma · CD19

#CD19#CGT#Phase1#세포유전치료#CAR-T+4

CGTBiologicstaleYang ZhangPhase 1

IL13Rα2 CAR-T (IL13Rα2 CAR-T)

Glioma · Glioma

#Glioma#CGT#Phase1#세포유전치료#CAR-T+2

CGTBiologicstaleMing YangPhase 1

IL13Rα2 CAR-T Cells Secreting Anti-PD-L1 Antibody (IL13Rα2 CAR-T Cells Secreting Anti-PD-L1 Antibody)

Recurrent Malignant Glioma · PD-L1

#PD-L1#CGT#Phase1#세포유전치료#CAR-T+3

ADCBiologicstaleImmunome, Inc.Phase 1

IM-1021 (IM-1021)

Solid Malignancies; Hematologic Malignancies · Solid Malignancies

#SolidMalignancies#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2

ADCBiologicstaleImmunome, Inc.Phase 1

IM-1617 (IM-1617)

Colorectal Cancer; Non-Small Cell Lung Cancer · Colorectal Cancer

#ColorectalCancer#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2

CGTBiologicstaleBeijing Immunochina Medical Sci…Phase 1

IM19 CAR-T (IM19 CAR-T)

Hematological Malignancies · Leukemia

#Leukemia#CGT#Phase1#세포유전치료#CAR-T+3

CGTBiologicstaleBeijing Immunochina Medical Sci…Phase 1

IM21 CAR-T cells (IM21 CAR-T cells)

Multiple Myeloma · Multiple Myeloma

#MultipleMyeloma#CGT#Phase1#세포유전치료#CAR-T+2

ADCBiologicstaleImmunoGen, Inc.Phase 2

IMGC936 (IMGC936)

Advanced Solid Tumor · Advanced Solid Tumor

#AdvancedSolidTumor#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1

효능 ORR 0%임상시험 1상태 ACTIVE

ADCBiologicstaleImmunoGen, Inc.Phase 1

IMGN289 (IMGN289)

EGFR Positive Solid Tumors · EGFR

#EGFR#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2

AntibodystaleImmuneering CorporationPhase 2

Treatment Group E (IMM-1-104 + pembrolizumab, IMM-1-104 + pembrolizumab (Treatment Group E))

Advanced Solid Tumor; Pancreatic Adenocarcinoma · Advanced Solid Tumor

#AdvancedSolidTumor#Antibody#Phase2#항체#면역항체+3

ADCBiologicstaleGilead SciencesPhase 2

IMMU-132 plus Carboplatin infusion (IMMU-132 plus Carboplatin infusion)

Triple-negative Breast Cancer · Triple-negative Breast Cancer

#Triple-negativeBreastCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1

ADCBiologicstaleInstitut Paoli-CalmettesPhase 1

INA03 administration (INA03 administration)

Acute Lymphoblastic Leukemia Recurrent; Acute Lymphoblastic Leukemia, in Relapse · Acute Lymphoblastic Leukemia Recurrent

#AcuteLymphoblasticLeukemiaRecurr#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+3